128 related articles for article (PubMed ID: 2516854)
1. Multiple myeloma: evidence that light chains play an immunoregulatory role in B-cell regulation.
Ioannidis RA; Joshua DE; Warburton PT; Francis SE; Brown RD; Gibson J; Kronenberg H
Hematol Pathol; 1989; 3(4):169-75. PubMed ID: 2516854
[TBL] [Abstract][Full Text] [Related]
2. Functional behaviour and immunological phenotype of circulating B lymphocytes in multiple myeloma. Studies with pokeweed mitogen.
Gobbi M; Caligaris-Cappio F; Campana D; Tazzari PL; Bergui L; Cavo M; Tura S
Clin Exp Immunol; 1984 Dec; 58(3):625-30. PubMed ID: 6439450
[TBL] [Abstract][Full Text] [Related]
3. Human B cells secrete predominantly lambda L chains in the absence of H chain expression.
Ambrosino DM; Kanchana MV; Delaney NR; Finberg RW
J Immunol; 1991 Jan; 146(2):599-602. PubMed ID: 1898958
[TBL] [Abstract][Full Text] [Related]
4. A human myeloma cell line that does not express immunoglobulin but yields a high frequency of antibody-secreting hybridomas.
Pickering JW; Gelder FB
J Immunol; 1982 Jul; 129(1):406-12. PubMed ID: 6806365
[TBL] [Abstract][Full Text] [Related]
5. Multiple myeloma with monoclonal IgG and IgD of lambda type exhibiting, under treatment, a shift from mainly IgG to mainly IgD.
Gallart T; Bladé J; MartÃnez-Quesada J; Sierra J; Rozman C; Vives J
Immunology; 1985 May; 55(1):45-57. PubMed ID: 3922877
[TBL] [Abstract][Full Text] [Related]
6. The surface expression of a tumor-associated antigen on human kappa myeloma cells.
Boux HA; Raison RL; Walker KZ; Musgrove E; Basten A
Eur J Immunol; 1984 Mar; 14(3):216-22. PubMed ID: 6423392
[TBL] [Abstract][Full Text] [Related]
7. Selective induction of light chain synthesis in cultures of blood lymphocytes from patients with IgG myelomatosis.
Walker LA; Johnson GD; MacLennan IC
Clin Exp Immunol; 1988 Jan; 71(1):193-7. PubMed ID: 2832107
[TBL] [Abstract][Full Text] [Related]
8. Mutations affecting immunoglobulin light chain secretion by myeloma cells. I. Functional analysis by cell fusion.
Mosmann TR; Baumal R; Williamson AR
Eur J Immunol; 1979 Jul; 9(7):511-6. PubMed ID: 115698
[TBL] [Abstract][Full Text] [Related]
9. Monitoring myeloma: light chain isotype suppression. A new parameter.
Wearne A; Joshua DE; Kronenberg H
Aust N Z J Med; 1985 Oct; 15(5):629-33. PubMed ID: 3937514
[TBL] [Abstract][Full Text] [Related]
10. Abnormal kappa:lambda light chain ratio in circulating immune complexes as a marker for B cell activity in juvenile idiopathic arthritis.
Low JM; Chauhan AK; Moore TL
Scand J Immunol; 2007 Jan; 65(1):76-83. PubMed ID: 17212770
[TBL] [Abstract][Full Text] [Related]
11. Pituitary adenylate cyclase-activating polypeptide is a potent inhibitor of the growth of light chain-secreting human multiple myeloma cells.
Li M; Cortez S; Nakamachi T; Batuman V; Arimura A
Cancer Res; 2006 Sep; 66(17):8796-803. PubMed ID: 16951196
[TBL] [Abstract][Full Text] [Related]
12. In vitro studies on human IgD. II. IgD-secreting cells preferentially elaborate IgD, lambda molecules.
Litwin SD; Zehr BD
Eur J Immunol; 1987 Apr; 17(4):491-5. PubMed ID: 3106066
[TBL] [Abstract][Full Text] [Related]
13. In vitro myotrophic effect of serum kappa chain immunoglobulins from a patient with kappa light chain myeloma and muscular hypertrophy.
Delaporte C; Varet B; Fardeau M; Nochy D; Ract A
J Clin Invest; 1986 Oct; 78(4):922-7. PubMed ID: 3093534
[TBL] [Abstract][Full Text] [Related]
14. Light chain isotype associated suppression of surface immunoglobulin expression on peripheral blood lymphocytes in myeloma during plateau phase.
Wearne A; Joshua DE; Kronenberg H
Br J Haematol; 1984 Nov; 58(3):483-9. PubMed ID: 6437432
[TBL] [Abstract][Full Text] [Related]
15. Mitogen-stimulated immunoglobulin production by chronic lymphocytic leukaemic lymphocytes.
Johnstone AP; Jensenius JC; Millard RE; Hudson L
Clin Exp Immunol; 1982 Mar; 47(3):697-705. PubMed ID: 6805990
[TBL] [Abstract][Full Text] [Related]
16. The establishment of a human myeloma cell line elaborating lambda-light chain protein.
Niho Y; Shibuya T; Yamasaki K; Kimura N
Int J Cell Cloning; 1984 May; 2(3):161-72. PubMed ID: 6429256
[TBL] [Abstract][Full Text] [Related]
17. Antigenic properties of human IgG Kappa and IgG lambda myeloma plasma cells.
Hagner G
Exp Hematol; 1983 Mar; 11(3):219-25. PubMed ID: 6403367
[TBL] [Abstract][Full Text] [Related]
18. Identification of the human T cell lymphoma virus in B cell lines established from patients with adult T cell leukemia.
Mann DL; Clark J; Clarke M; Reitz M; Popovic M; Franchini G; Trainor CD; Strong DM; Blattner WA; Gallo RC
J Clin Invest; 1984 Jul; 74(1):56-62. PubMed ID: 6330177
[TBL] [Abstract][Full Text] [Related]
19. Human autoantibody silencing by immunoglobulin light chains.
Wardemann H; Hammersen J; Nussenzweig MC
J Exp Med; 2004 Jul; 200(2):191-9. PubMed ID: 15263026
[TBL] [Abstract][Full Text] [Related]
20. Absence of immunoglobulin heavy chain expression results in altered kappa/lambda light chain ratios.
Holmberg D; Lundkvist I; Forni L; Ivars F; Coutinho A
J Mol Cell Immunol; 1985; 2(1):51-6. PubMed ID: 3939751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
